These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22689691)

  • 1. Significance of IGFBP-4 in the development of fetal growth restriction.
    Qiu Q; Bell M; Lu X; Yan X; Rodger M; Walker M; Wen SW; Bainbridge S; Wang H; Gruslin A
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1429-39. PubMed ID: 22689691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
    Giudice LC; Conover CA; Bale L; Faessen GH; Ilg K; Sun I; Imani B; Suen LF; Irwin JC; Christiansen M; Overgaard MT; Oxvig C
    J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
    Sun IY; Overgaard MT; Oxvig C; Giudice LC
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
    Han VK; Bassett N; Walton J; Challis JR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.
    Crosley EJ; Dunk CE; Beristain AG; Christians JK
    Reprod Biol Endocrinol; 2014 Dec; 12():123. PubMed ID: 25475528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.
    Street ME; Seghini P; Fieni S; Ziveri MA; Volta C; Martorana D; Viani I; Gramellini D; Bernasconi S
    Eur J Endocrinol; 2006 Oct; 155(4):567-74. PubMed ID: 16990656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.
    Byun D; Mohan S; Yoo M; Sexton C; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2001 Feb; 86(2):847-54. PubMed ID: 11158056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia.
    Gratton RJ; Asano H; Han VK
    Placenta; 2002 Apr; 23(4):303-10. PubMed ID: 11969341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P; Liu B; Li G; Wu L; Yu M; Ou Y; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pregnancy-associated plasma protein A and insulin-like growth factor system in response to cigarette smoking.
    Chelchowska M; Maciejewski T; Gajewska J; Ambroszkiewicz J; Laskowska-Klita T; Leibschang J
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2377-80. PubMed ID: 22630333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered placental structure induced by maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the mother?
    Roberts CT; Sohlstrom A; Kind KL; Grant PA; Earl RA; Robinson JS; Khong TY; Owens PC; Owens JA
    Placenta; 2001 Apr; 22 Suppl A():S77-82. PubMed ID: 11312635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
    Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
    J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
    Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM
    Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
    DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
    Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation.
    Irwin JC; Suen LF; Faessen GH; Popovici RM; Giudice LC
    J Clin Endocrinol Metab; 2001 May; 86(5):2060-4. PubMed ID: 11344207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
    Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
    Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.